(in million €) 2018 - H2 2019 - H2 2018 2019
Recurring EBITDA (16) (14) (35) (32)
Recurring EBIT (21) (22) (46) (47)
   of which associates 2 1 5 5
Total EBIT (22) (25) (39) (50)
R&D expenditure 4 5 7 10
Capital expenditure 10 9 14 19
Capital employed, end of period 222 176 222 176
Capital employed, average 204 186 191 197
Workforce, end of period (fully consolidated) 1.070 1.116 1.070 1.116
Workforce, end of period (associates) 2.398 2.225 2.398 2.225